Editorial Feature

Researching Cancer with Nuclear Magnetic Resonance (NMR) Spectroscopy

Nuclear magnetic resonance (NMR) spectroscopy can be used to determine chemical structures and, in some cases, chemical dynamics. By probing the intrinsic spin properties of nuclei, NMR can identify local chemical environments and selective probe atomic species.

cancer, nmr spectroscopy

Image Credit: crystal light/Shutterstock.com

NMR is not just suited to identifying chemically distinct species but can also be used to disentangle different conformers.1 Conformational isomers, or conformers, are molecules with the same atomic composition and connectivity between the atoms. However, they differ in their geometric arrangement. With most conformers, it is possible to interconvert between the different isomeric forms by undergoing some kind of rotational motion.

While conformers may not be distinct in terms of their elemental composition, they can have very different behavior and interactions with other molecular species. Many biological species, including proteins, have a huge number of different conformers. A protein is constructed from building blocks known as amino acids. These amino acid sequences are then linked together with peptide bonds to form the protein structure.

One amino acid, proline, has some unusual properties. When peptide bonds are formed with proline, they can adopt either the cis or trans isomeric forms. While usually the trans form is favored, the interconversion between the cis and trans conformers can play an important role in protein folding.2

Intrinsically Disordered Proteins

Most proteins will have several stable conformers that they can interconvert between but are generally fixed in one secondary structure. However, intrinsically disordered proteins have a much greater degree of conformational flexibility meaning they can bind to multiple targets and may prove a valuable target to drug therapies to aid in the treatment of diseases such as cancer.

Prolines have an important contribution to this conformational flexibility due to their abilities to contribute to cis/trans isomerization in the protein. While this conformational flexibility of intrinsically disordered proteins is interesting from a biomedical perspective for treatments and protein behavior, being able to measure the exact contributions of the amino acids to a given structure or discern the different conformational structures is key to the development of new therapies that make use of these proteins.

Recent work from a collaboration between the Eötvös Loránd University, Hungary, KIT University in Karlsruhe, Germany, and Bruker has involved developing a NMR method that captures these shifting structures for characterization.3

NMR Methods

By focusing on 1Hα NMR, the team captured proline-specific signatures for investigation. The challenge they faced was the concentrations of the different isomers could be as low as 5 ppm in some cases. Due to the small energy difference between the two spin states of the atoms of interest, NMR is a relatively insensitive technique. This usually means measurements require large amounts of the sample or long acquisition times.

To capture the dynamical behavior and interconversion between the conformers, long measurement times were not possible as the resulting signal would represent an average of all the different structures the protein had sampled during the measurement.

The new method developed by the team makes use of real-time homodecoupled sequences. Previously, making such measurements on profile to understand the conformational dynamics would have involved making various chemical substitutions on different parts of the protein to investigate the difference between the conformers and try and ‘lock’ certain structures for the duration of the measurement.

With the new methodology, a standard NMR spectrometer can be programmed with the right pulse sequence to make sure of this fast experimental detection times without the need for any additional equipment. This makes NMR a very attractive candidate for structure studies on these types of proteins. NMR is also very attractive as a tool for conformation studies as other structurally sensitive techniques, such as X-ray crystallography or cryo-EM, cannot follow the dynamical processes in the protein. This is because the freezing or crystallization process locks the protein into a particular form.

As well as the ease of use and the lack of need for additional, specialized equipment, another positive aspect of the new NMR methodology is that measurements with this method can be made under physiological conditions. Direct measurements on cells and tissues are often not possible with advanced analytical techniques but given the sensitivity of the protein structure to its environment, it is important that the measurements imitate the ‘real’ environmental conditions for the protein as closely as possible.

The team focused on profiling p53TAD with its new method, which is an example of a disordered p53. p53 is a gene that makes a tumor-suppressor protein and mutations of this gene lead to the formation of cancers. By studying the conformations of p53TAD, it is possible to understand what types of drug structure might be well-suited for targeting genes of this type and help drive better cures for cancers.

References and Further Reading

  1. Tormena, C. F., Cormanich, R. A., & Rittner, R. (2011). AUREMN NMR Spectroscopy : a Tool for Conformational Analysis. Annual Reviews of Magnetic Resonance, 10(1/2), 1–27. http://www.auremn.org.br/Annals/2011-vol10-num1/AMR2011v10n12p1-27.pdf
  2. Wedemeyer, W. J., Welker, E., & Scheraga, H. A. (2002). Current Topics Proline Cis - Trans Isomerization and Protein Folding. Biochemistry, 41, 14637–14644. https://doi.org/10.1021/bi020574b
  3. Sebák, A. F., Ecsédi, P., Bermel, W., & Luy, B. (2021). Selective 1Hα NMR methods to reveal functionally relevant proline cis/trans isomers in IDPs: characterization of minor forms, effects of phosphorylation and occurrence in proteome. Angewandte Chemie - International Edition. https://doi.org/10.1002/anie.202108361

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Rebecca Ingle, Ph.D

Written by

Rebecca Ingle, Ph.D

Dr. Rebecca Ingle is a researcher in the field of ultrafast spectroscopy, where she specializes in using X-ray and optical spectroscopies to track precisely what happens during light-triggered chemical reactions.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ingle, Rebecca. (2021, November 24). Researching Cancer with Nuclear Magnetic Resonance (NMR) Spectroscopy. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/Article.aspx?ArticleID=2063.

  • MLA

    Ingle, Rebecca. "Researching Cancer with Nuclear Magnetic Resonance (NMR) Spectroscopy". AZoOptics. 21 November 2024. <https://www.azooptics.com/Article.aspx?ArticleID=2063>.

  • Chicago

    Ingle, Rebecca. "Researching Cancer with Nuclear Magnetic Resonance (NMR) Spectroscopy". AZoOptics. https://www.azooptics.com/Article.aspx?ArticleID=2063. (accessed November 21, 2024).

  • Harvard

    Ingle, Rebecca. 2021. Researching Cancer with Nuclear Magnetic Resonance (NMR) Spectroscopy. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/Article.aspx?ArticleID=2063.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.